The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
about
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The VEGF-A inhibitor sFLT-1 im ...... ouse model of type 1 diabetes.
@en
type
label
The VEGF-A inhibitor sFLT-1 im ...... ouse model of type 1 diabetes.
@en
prefLabel
The VEGF-A inhibitor sFLT-1 im ...... ouse model of type 1 diabetes.
@en
P2093
P2860
P1433
P1476
The VEGF-A inhibitor sFLT-1 im ...... ouse model of type 1 diabetes.
@en
P2093
Jan A Bruijn
Marion Scharpfenecker
Pascal Bus
Priscilla Van Der Wilk
Ron Wolterbeek
P2860
P2888
P304
P356
10.1007/S00125-017-4322-3
P50
P577
2017-06-15T00:00:00Z